GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric ...

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...

Neuroscientist Sabina Brennan encourages caregivers to live in the moment and notice the happy experiences they share with ...

Key messages • It is known that older people who take more medicines with an anticholinergic effect may be at greater risk of cognitive decline. • There is a lack of high-quality evidence to show ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

Results from this study show that there is a direct correlation between the use of anti-obesity medications and testosterone levels,” the study author said.

It may be possible to detect Alzheimer’s risk sooner—as early as your 20s Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers ...

A multi-strain probiotic blend shows promise for protecting brain function by reducing gut-triggered inflammation linked to Alzheimer’s disease. Hariom Yadav, PhD, keeps thinking about a particular ...

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and eyes. Learn the signs and symptoms.